East North Central U.S. Prostate Cancer Survival Rates News Monitoring

Get by Email • RSS

Published on May 30, 2025

Phase 2 trial launches of combination immunotherapy for mCRPC

The first patient has been dosed in the phase 2a LEGION-100 trial (NCT06533644), evaluating the safety, tolerability, and preliminary efficacy of SYNC-T therapy SV-102 in patients with metastatic castration-resistant prostate cancer (mCRPC).1 According to …

Source: Urology Times - Pending
Published on May 28, 2025

Advancements in Nanocarrier Delivery Systems for Photodynamic Therapy in Lung Cancer

Introduction A recent report by the International Agency for Research on Cancer estimated that approximately 19.3 million new cancer cases and 9.9 million cancer-related deaths occurred globally in 2020.1 The report also predicts a 56.4% increase in these …

Source: Dove Medical Press - Neutral

days

hours

minutes

seconds

Featured Releases

Got News to Share? · Submit · See All

Published on May 31, 2025 - 12:00 GMT

Harbinger Health Showcases Multi-Cancer Early Detection Performance in High-Risk Populations at ASCO 2025

Reflex blood-based multi-cancer early detection (MCED) test demonstrated clinically meaningful per-cancer Positive Predictive Value (PPV) and early-stage sensitivity for multiple cancers with elevated incidence and mortality in a high-risk population Data …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...
Published on May 30, 2025 - 12:30 GMT

Syncromune® Announces First Patient Dosed in LEGION-100 Phase 2a Trial of SYNC-T® Therapy SV-102 for Patients with ...

FORT LAUDERDALE, Fla. and WEST DES MOINES, Iowa, May 30, 2025 (GLOBE NEWSWIRE) -- Syncromune® Inc., a clinical-stage biopharmaceutical company focused on the development of SYNC-T, an in situ personalized combination immunotherapy platform optimized for …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on May 29, 2025 - 14:04 GMT

Collaborations for Change: AUA and Pfizer Select Recipients for $1.5 Million Grant Program to Improve Advanced Prostate ...

BALTIMORE, May 29, 2025 (GLOBE NEWSWIRE) -- The American Urological Association (AUA) is excited to announce it has selected seven grant winners to split $1.5 million as part of a collaborative initiative with Pfizer External Research & Grants (ER& …

Distribution channels: Media, Advertising & PR ...
Published on May 29, 2025 - 12:18 GMT

Voltron Therapeutics, Inc., a Lucius Partners Portfolio Company, Announces Definitive Proof of Concept Data for its ...

Study conducted at The Massachusetts General Hospital’s Vaccine and Immunotherapy Center demonstrated highly significant improvements in Overall Survival and other key endpoints VTX-0P4, in combination with a CPI, had a statistically significant …

Distribution channels: Consumer Goods, Healthcare & Pharmaceuticals Industry ...

Published on May 28, 2025 - 12:05 GMT

Candel Therapeutics Receives FDA Regenerative Medicine Advanced Therapy Designation for CAN-2409 for the Treatment of ...

NEEDHAM, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...
Published on May 29, 2025 - 11:53 GMT

Comprehensive Insights of Global Urinary Retention Therapeutics Market: Drivers, Trends, Opportunities, 2025–2034

The Business Research Company's Urinary Retention Therapeutics Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 29, 2025 /⁨EINPresswire.com⁩/ -- From $3.33 billion in …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on June 2, 2025 - 05:00 GMT

Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options ...

Ad-hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE WYOST® (denosumab-bbdz) and Jubbonti® (denosumab-bbdz) are first and only FDA-approved interchangeable denosumab biosimilars available in US Improves access for patients …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on June 2, 2025 - 07:16 GMT

Trump's mocking conspiracy suggests Biden is ‘robotic clone’

(MENAFN) Leader Donald Trump has circulated a controversial theory online suggesting that Joe Biden, his predecessor, was secretly executed and substituted with a mechanical duplicate. An anonymous social media post, first appearing on Saturday afternoon, …

Distribution channels: ...

Got news to share? Submit it now.

Load more prostate cancer news or search news using your own keywords. There are 818,189,850 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Prostate Cancer News by Country

Prostate Cancer News by U.S. State

Prostate Cancer News Topics

Online News Publications

World News Report

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter

Create RSS Feed

NewsPlugin for WordPress

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire

Events

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 05/18/2025

World Media Directory

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Published on June 2, 2025 - 06:51 GMT

Narconon Arrowhead Hosts Celebration for Graduate's 25 Years of Sobriety

CANADIAN, OK, UNITED STATES, June 1, 2025 /⁨EINPresswire.com⁩/ -- The Narconon Arrowhead Drug and Alcohol Rehabilitation Program recently hosted a special celebration as Bobby Newman, a program graduate, marked 25 years of sobriety. Newman, who …

Distribution channels: Culture, Society & Lifestyle, Education ...
Published on June 1, 2025 - 23:16 GMT

Luis M. Gallardo Launches the Meta Pets Method, A Playful Path to Transformation for Therapists, Coaches, and Educators

A Card-Based System for Self-Inquiry, Healing, and Awakening in Education, Coaching, and Therapy. MIAMI, FL, UNITED STATES, June 1, 2025 /⁨EINPresswire.com⁩/ -- Author, hypnotherapist, and global well-being advocate Luis Miguel Gallardo announces …

Distribution channels: Book Publishing Industry, Business & Economy ...
Published on June 1, 2025 - 23:00 GMT

Impelsys Strengthens AI Transformation Strategy with AlgoShack Partnership

NEW YORK, NY, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- Impelsys, a global leader in technology solutions, is pleased to announce its strategic partnership with AlgoShack, a company that offers algoQA—a unified platform for end-to-end …

Distribution channels: Book Publishing Industry, Education ...
Published on June 2, 2025 - 05:00 GMT

Zealand Pharma submits Marketing Authorization Application to the European Medicines Agency for glepaglutide in short ...

Press release – No. 10 / 2025 Zealand Pharma submits Marketing Authorization Application to the European Medicines Agency for glepaglutide in short bowel syndrome Copenhagen, Denmark, June 2, 2025 – Zealand Pharma A/S (Nasdaq: ZEAL) (“Zealand”) ( …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 2, 2025 - 05:00 GMT

Press Release: Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-...

Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology Adds fast-growing and only approved medicine for advanced and indolent systemic mastocytosis to the Sanofi portfolio …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on June 2, 2025 - 05:00 GMT

Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options ...

Ad-hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE WYOST® (denosumab-bbdz) and Jubbonti® (denosumab-bbdz) are first and only FDA-approved interchangeable denosumab biosimilars available in US Improves access for patients …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on June 2, 2025 - 05:00 GMT

Communiqué de presse : Sanofi acquiert Blueprint Medicines, enrichit son portefeuille dans les maladies immunologiques ...

Sanofi acquiert Blueprint Medicines, enrichit son portefeuille dans les maladies immunologiques rares et ajoute un pipeline d’immunologie de stade précoce Le portefeuille de Sanofi s’enrichit du seul médicament approuvé, en croissance rapide, pour la …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on June 2, 2025 - 02:29 GMT

Colorado public health officials release additional locations for potential measles exposures

The DEN airport case has resulted in three additional confirmed cases of measles Denver (June 1, 2025) — The Colorado Department of Public Health and Environment and El Paso County Public Health have confirmed measles in two adult unvaccinated El Paso …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on June 2, 2025 - 02:06 GMT

Volunteers support the NHS for 6 million hours this year

Tens of thousands of people have volunteered to help the NHS over the last year, according to new figures. From people in their late teens to those in their late eights volunteers have helped with tasks such as directing loved ones around hospitals, …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on June 2, 2025 - 00:00 GMT

HUTCHMED Highlights SACHI Phase III Study Data Presented at the 2025 ASCO Annual Meeting

— The all-oral chemotherapy-free combination of savolitinib plus osimertinib demonstrated significant PFS benefit with a favorable safety profile in the SACHI Phase III China study — — Webcast to be held at 8:30 am HKT on Tuesday, June 3 to discuss the …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on June 1, 2025 - 23:30 GMT

Nxera Pharma Achieves Development Milestone in Collaboration with Eli Lilly Targeting Metabolic Diseases

Tokyo, Japan and Cambridge, UK, 2 June 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) today announces that it has achieved a development milestone under its multi-target collaboration and license agreement with Eli Lilly and Company (“ …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on June 1, 2025 - 23:26 GMT

TORRAS Personal Cooling with Coolify Series: A Tech-Driven Solution for Comfort, Wellness, and Women's Health

LOS ANGELES, June 01, 2025 (GLOBE NEWSWIRE) -- As global temperatures continue to rise and daily comfort becomes a growing concern, TORRAS is making waves with its innovative Coolify series—a wearable air conditioner engineered to deliver rapid, personal …

Distribution channels:
Published on June 1, 2025 - 23:00 GMT

Kura Oncology and Kyowa Kirin Announce FDA Acceptance and Priority Review of New Drug Application for Ziftomenib in ...

– New Drug Application based on positive results from the Phase 2 KOMET-001 trial – – FDA assigns a Prescription Drug User Fee Act (PDUFA) target action date of November 30, 2025 – – Potential first approval of a menin inhibitor for the treatment of adult …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
Published on June 1, 2025 - 05:21 GMT

Smile Scarsdale Family Dental Celebrates One Year of Smiles as Trusted Family Dentist in Scarsdale

SCARSDALE, NY, UNITED STATES, May 31, 2025 /⁨EINPresswire.com⁩/ -- Smile Scarsdale Family Dental is proud to celebrate its one-year anniversary of delivering exceptional family dental care to the Scarsdale community and surrounding areas. Since …

Distribution channels: Culture, Society & Lifestyle, Emergency Services ...
Published on June 1, 2025 - 17:12 GMT

Bicara Therapeutics Demonstrates Deep and Durable Responses with Ficerafusp Alfa Plus Pembrolizumab in 1L HPV-Negative R/...

Median DOR of 21.7 months with 80% of responders achieving a deep response (≥80% tumor shrinkage) Depth and durability translating to prolonged OS with median OS of 21.3 months and 2-year OS of 46% in HPV-negative HNSCC Conference call and webcast today at …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 1, 2025 - 14:45 GMT

Allogene Therapeutics Provides Updated Phase 1 Data Highlighting Durable Responses with ALLO-316 in Heavily Pretreated ...

Data Highlights Transformative Promise of CAR T in Solid Tumors Phase 1 Trial with ALLO-316 Demonstrated Potential to Provide Meaningful Clinical Benefit in Patients with CD70 TPS ≥ 50% Advanced or Metastatic RCC A Single Dose of ALLO-316 Achieved a 31% …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 1, 2025 - 14:00 GMT

Replimune Presents New Analyses from the IGNYTE Study of RP1 plus Nivolumab in Anti-PD1 Failed Melanoma at the 2025 ...

- RP1 plus nivolumab generated robust responses in both injected and non-injected lesions - - Deep/visceral injections, including into the liver and lung, resulted in numerically higher rates of response compared to superficial injections only and were …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...
Published on June 1, 2025 - 00:41 GMT

Planet TV Studios Presents New Frontiers Episode 'Highlighting Emerging Technologies' Featuring Athena Clinic & Dr. ...

Planet TV Studios proudly serves as the exclusive sponsor of the New Frontiers series. New Frontiers: "Highlighting Emerging Technologies" will air May 31st 2025 on Bloomberg Television at 5:00 pm ET. BOCA RATON,, FL, UNITED STATES, May 31, 2025 …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on June 1, 2025 - 00:35 GMT

Planet TV Studios Presents New Frontiers: Innovators Shaping Tomorrow. The content in the episode is a Planet TV Studios ...

Planet TV Studios proudly serves as the exclusive sponsor of the New Frontiers series. New Frontiers: "Highlighting Emerging Technologies" will air May 31st 2025 on Bloomberg Television at 5:00 pm ET. BOCA RATON, FL, UNITED STATES, May 31, 2025 …

Distribution channels: Companies, Culture, Society & Lifestyle ...
Published on June 1, 2025 - 00:33 GMT

'New Frontiers' Presents 4 Companies Revolutionizing: Brian Cancer Therapies, Robotic Surgery, Sustainable Solutions & ...

Planet TV Studios proudly serves as the exclusive sponsor of the New Frontiers series. New Frontiers: "Highlighting Emerging Technologies" will air May 31st 2025 on Bloomberg Television at 5:00 pm ET. BOCA RATON, FL, UNITED STATES, May 31, 2025 …

Distribution channels: Companies, Culture, Society & Lifestyle ...